Increase translational success with our in vitro assays

We use genetic engineering technologies in human tissue and patient-derived cancer cells to provide cost-effective in vitro assays to predict the efficacy and safety of drugs in human cells and organs. In addition, these genetically engineered human patient-derived cells can be transplanted back into rodent models to study and optimize RNAi and CRISPR-based therapeutics in a whole organism. Mirimus' in vitro assays empower researchers to investigate factors that underpin pathogenesis, resistance, and susceptibility to cancer, and to discover entirely new set of potential targets.


Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Black and white Mirimus log

760 Parkside Avenue, Suite 206
Brooklyn, NY 11226

Phone: +1 (833) 647-4687